The Bishop of St Albans received the following written answer on 7th September 2023:
The Lord Bishop of St Albans asked His Majesty’s Government what assessment they have made of the efficacy of Vorasidenib for the treatment of brain tumours.
Lord Markham (Con, Department of Health & Social Care): In the United Kingdom, medicines need to have a licence before they can be marketed, and these are granted by the Medicines and Healthcare products Regulatory Agency (MHRA). The MHRA has not issued a scientific opinion for Vorasidenib. Should an application for Vorasidenib be received, the MHRA will consider this accordingly.
The Church of England in Parliament 
You must be logged in to post a comment.